Singh Meghna, Srivastava K K, Bhattacharya Shailja M
Division of Parasitology, Central Drug Research Institute, P.O. Box-173, Lucknow 226001, India.
Parasitol Res. 2009 Mar;104(4):753-61. doi: 10.1007/s00436-008-1251-6. Epub 2008 Nov 11.
DEAD box proteins are putative RNA unwinding proteins found in organisms ranging from mammals to bacteria. We have identified a novel immunodominant cDNA clone, BmL3-helicase, encoding DEAD box RNA helicase by immunoscreening of a larval stage cDNA library of Brugia malayi. The cDNA sequence exhibited strong sequence homology to Caenorhabditis elegans and C. briggsae RNA helicase, a prototypic member of the DEAD (Asp-Glu-Ala-Asp) box protein family. The clone also showed similarity with RNA helicase of Wolbachia, an endosymbiotic bacterium of filarial parasite. It was overexpressed as approximately 50 kDa His-tag fusion protein, and ATP hydrolysis assay of recombinant enzyme showed that either ATP or dATP was required for the unwinding activity, indicating BmL3-helicase as an ATP/dATP-dependent RNA helicase. The recombinant protein also demonstrated cross-seroreactivity with human bancroftian sera. The presence of BmL3-helicase in various life stages of B. malayi was confirmed by immunoblotting of parasite-life-cycle extracts with polyclonal sera against the BmL3-helicase, which showed high levels of expression in microfilaria, L(3,) and adult (both male and female) stages. In the absence of an effective macrofilaricidal agent and validated anti-filarial drug targets, RNA helicases could be utilized as a rational drug target for developing agents against the human filarial parasite.
DEAD盒蛋白是在从哺乳动物到细菌等多种生物体中发现的假定的RNA解旋蛋白。我们通过对马来布鲁线虫幼虫期cDNA文库进行免疫筛选,鉴定出了一个新的免疫显性cDNA克隆BmL3解旋酶,它编码DEAD盒RNA解旋酶。该cDNA序列与秀丽隐杆线虫和briggsae线虫的RNA解旋酶(DEAD(天冬氨酸-谷氨酸-丙氨酸-天冬氨酸)盒蛋白家族的原型成员)具有很强的序列同源性。该克隆还与丝虫寄生虫的内共生细菌沃尔巴克氏体的RNA解旋酶相似。它作为约50 kDa的His标签融合蛋白被过度表达,重组酶的ATP水解试验表明,解旋活性需要ATP或dATP,这表明BmL3解旋酶是一种ATP/dATP依赖性RNA解旋酶。重组蛋白还与人班氏丝虫血清表现出交叉血清反应性。用针对BmL3解旋酶的多克隆血清对寄生虫生命周期提取物进行免疫印迹,证实了BmL3解旋酶在马来布鲁线虫各个生命阶段的存在,结果显示其在微丝蚴、L(3)和成虫(雄性和雌性)阶段均有高水平表达。在缺乏有效的杀成虫剂和经过验证的抗丝虫药物靶点的情况下,RNA解旋酶可作为开发抗人丝虫寄生虫药物的合理药物靶点。